Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,012 stories, page 705 of 767

Advanced search

🇺🇸May 30, 2025Industryclinicalink.comTier 1 · Company source

Dr. Nicholas Alp Speaks with Clinical Trials Arena about Progress of Patient-Centric Trials

Clinical InkOriginal source

🇦🇹May 30, 2025Devicescontextflow.comTier 1 · Company source

contextflow & Curagita partner to improve lung cancer and lung disease diagnostics in Germany

contextflow (ADVANCE Chest CT Lung)Original source

🇦🇹May 30, 2025Devicescontextflow.comTier 1 · Company source

UZ Leuven and contextflow Collaborate on a Pilot to Advance Chest Imaging Analysis

contextflow (ADVANCE Chest CT Lung)Original source

🇺🇸May 29, 2025Industrycapsida.comTier 1 · Company source

Capsida Receives FDA Fast Track Designation for Its Potential First-in-Class IV-Administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy

Capsida BiotherapeuticsOriginal source

🇺🇸May 28, 2025CROcelerion.comTier 2 · Direct publisher

The Rising Tide of Weight Reduction Therapies

CelerionOriginal source

🇧🇷May 28, 2025Researchfiocruz.brTier 2 · Direct publisher

Ciência e Saúde pela Vida: 125 anos de história da Fiocruz

Fiocruz NewsOriginal source

🇧🇷May 28, 2025Researchfiocruz.brTier 2 · Direct publisher

Science on the Trail to the Backlands: photographs of the scientific expeditions by the Oswaldo Cruz Institute to the hinterlands of Brazil from 1911 to 1913

Fiocruz NewsOriginal source

🇺🇸May 27, 2025CDMOveranex.comTier 2 · Direct publisher

Veranex Appoints Morwan Choli, PhD as Senior Vice President of Global Regulatory Affairs and Quality

VeranexOriginal source

🌍May 27, 2025Industryabelzeta.comTier 1 · Company source

AbelZeta Receives RMAT Designation for C-CAR168 for the Treatment of Refractory SLE, Including LN

AbelZeta PharmaOriginal source

🌍May 27, 2025Mediacentogene.comTier 2 · Direct publisher

Strategic Partnership in Italy between CENTOGENE and Bianalisi

CentogeneOriginal source

🇺🇸May 27, 2025CDMOfmcbiopolymer.comTier 2 · Direct publisher

Breakthroughs in Glycan Biosynthesis: Transforming the Future of Biotechnological Production and Therapeutics

FMC BiopolymerOriginal source

🇺🇸May 24, 2025Industryneogenomics.comTier 1 · Company source

c-MET CDx for NSCLC

NeoGenomicsOriginal source

🇺🇸May 24, 2025Devicesnatus.comTier 1 · Company source

how point of care eeg helps overcome challenges of acute neurology care

Natus Medical (ArchiMed Group)Original source

🌍May 21, 2025Industryperspective.comTier 1 · Company source

Perspective shares CSO and R&D Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 21, 2025Industryperspective.comTier 1 · Company source

Perspective shares CMO Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 21, 2025Industryperspective.comTier 1 · Company source

Perspective shares CFO and Board Director Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 21, 2025Industryperspective.comTier 1 · Company source

Perspective shares CBO and COO Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 21, 2025Industryperspective.comTier 1 · Company source

Blog 3 — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 21, 2025Industrymaravai.comTier 1 · Company source

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

Maravai LifeSciencesOriginal source

🌍May 20, 2025Mediaprecisionformedicine.comTier 2 · Direct publisher

Precision Announces Promotion of Sofia Baig to President, Precision for Medicine and Appointment of Daisy DeWeese-Gatt, MPH, as President, Clinical Solutions, Precision for Medicine

Precision for MedicineOriginal source

🌍May 19, 2025Mediacentogene.comTier 2 · Direct publisher

CENTOGENE at ESHG 2025

CentogeneOriginal source

🇺🇸May 19, 2025Industrybeamtx.comTier 1 · Company source

Sitemap | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 19, 2025Industrybeamtx.comTier 1 · Company source

Base Editing Applications | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍May 19, 2025Industrypowerfulmedical.comTier 1 · Company source

Introducing PMcardio for Individuals 3.0: A New Era in AI-Powered Second Opinions for ECG Interpretation

Powerful MedicalOriginal source

🇫🇷May 16, 2025Industryastraveus.comTier 1 · Company source

Download Poster: Small is Powerful: Demonstrating the Potential of a Novel Microfluidic Benchtop Cell Factory

AstraveusOriginal source

🇨🇦May 15, 2025Devicesprofoundmedical.comTier 1 · Company source

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Profound MedicalOriginal source

🇨🇦May 15, 2025Devicesprofoundmedical.comTier 1 · Company source

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Profound MedicalOriginal source

🇺🇸May 14, 2025Industrycapsida.comTier 1 · Company source

Capsida Presents New GLP Toxicology Data Supporting Recent FDA IND Clearance of Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy

Capsida BiotherapeuticsOriginal source

🌍May 14, 2025Industryfidson.comTier 1 · Company source

Fidson Leads the Future of Sustained Growth in Healthcare

Fidson HealthcareOriginal source

🌍May 13, 2025Regulatoryima.isTier 1 · Regulatory source

RMS requests and national applications

IMA IcelandOriginal source

🇺🇰May 13, 2025Industryadaptimmune.comTier 1 · Company source

Adaptimmune Reports Q1 Financial Results and Provides Business Update

AdaptimmuneOriginal source

🌍May 13, 2025Mediaoxipit.aiTier 2 · Direct publisher

Diagnostic confidence at speed: how FIDI uses Oxipit AI through CARPL in emergency care

Oxipit (ChestLink for Thoracic X-ray/CT)Original source

🇺🇸May 13, 2025Devicesnatus.comTier 1 · Company source

accelerating seizure intervention acute neurological care

Natus Medical (ArchiMed Group)Original source

🇺🇸May 13, 2025Devicesfoundationmedicine.comTier 1 · Company source

Meet Foundation Medicine’s FlexOMx Lab™: A Flexible Research Lab to Support the Development of New Medicines

Foundation MedicineOriginal source

🇺🇸May 12, 2025Industrycapsida.comTier 1 · Company source

Capsida Receives FDA IND Clearance for Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy

Capsida BiotherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Presentations and Publications | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

RNA editing with CRISPR-Cas13 | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Improved base excision repair inhibition and bacteriophage | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions | Beam Therapeutics

Beam TherapeuticsOriginal source

🇺🇸May 10, 2025Industrybeamtx.comTier 1 · Company source

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage | Beam Therapeutics

Beam TherapeuticsOriginal source

🌍May 9, 2025Regulatoryravimiamet.eeTier 1 · Regulatory source

2024 Pharmacy Statistics: Key Figures and Trends

SAM EstoniaOriginal source

🇨🇦May 9, 2025Devicesprofoundmedical.comTier 1 · Company source

Profound Medical Announces First Quarter 2025 Financial Results

Profound MedicalOriginal source

🇨🇦May 9, 2025Devicesprofoundmedical.comTier 1 · Company source

Profound Medical Announces First Quarter 2025 Financial Results

Profound MedicalOriginal source

🇫🇷May 9, 2025Industryastraveus.comTier 1 · Company source

BioProcess Insider on Astraveus & NecstGen CGT Bottlenecks

AstraveusOriginal source

🌍May 8, 2025Industrycorbus.comTier 1 · Company source

Navigating Tariffs and Sanctions in Your Supply Chain

Corbus PharmaceuticalsOriginal source

🌍May 8, 2025Industryanaptysbio.comTier 1 · Company source

Why amet lorem dolor glavrida agestas

AnaptysBioOriginal source

🌍May 8, 2025Industryperspective.comTier 1 · Company source

Perspective shares CFO and Board Director Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 8, 2025Industryperspective.comTier 1 · Company source

Perspective shares CBO and COO Insights and Successes — Perspective Group

Perspective TherapeuticsOriginal source

🌍May 8, 2025Industryanaptysbio.comTier 1 · Company source

Dolor sit amet – consectetur adipiscing

AnaptysBioOriginal source

🌍May 8, 2025Devicesdigitaldiagnostics.comTier 1 · Company source

How One Health System Is Embedding Diabetic Retinopathy Screening Into Primary Care

IDx (Digital Diagnostics)Original source

🌍May 8, 2025Devicesdigitaldiagnostics.comTier 1 · Company source

15 Real-World Examples of AI Solving Complex Problems Across Industries Today

IDx (Digital Diagnostics)Original source

🇺🇰May 8, 2025Industryadaptimmune.comTier 1 · Company source

Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025

AdaptimmuneOriginal source

🌍May 7, 2025Mediaperspectum.comTier 2 · Direct publisher

Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes

PerspectumOriginal source

🌍May 7, 2025Industrycerbios.swissTier 3 · Secondary coverage

HAS Healthcare Advanced Synthesis completes the acquisition of Cerbios

Cerbios-Pharma SAOriginal source

🇫🇷May 7, 2025Industryastraveus.comTier 1 · Company source

GEN News: Astraveus & NecstGen CAR-T Partnership

AstraveusOriginal source

🇫🇷May 7, 2025Industryastraveus.comTier 1 · Company source

Cell & Gene Therapy Review: Astraveus & NecstGen CAR-T Collaboration

AstraveusOriginal source

🌍May 6, 2025Mediacentogene.comTier 2 · Direct publisher

CENTOGENE is now officially in Brazil

CentogeneOriginal source

🌍May 6, 2025Mediahealx.aiTier 2 · Direct publisher

Healx Appoints Christopher Moertel as Global Head of Clinical Development

HealxOriginal source